Follow
Jan Terje Andersen
Jan Terje Andersen
Verified email at medisin.uio.no
Title
Cited by
Cited by
Year
The neonatal Fc receptor (FcRn): a misnomer?
M Pyzik, KMK Sand, JJ Hubbard, JT Andersen, I Sandlie, RS Blumberg
Frontiers in immunology 10, 1540, 2019
3592019
Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
JC Holter, SE Pischke, E de Boer, A Lind, S Jenum, AR Holten, K Tonby, ...
Proceedings of the National Academy of Sciences 117 (40), 25018-25025, 2020
3252020
Unraveling the interaction between FcRn and albumin: opportunities for design of albumin-based therapeutics
KMK Sand, M Bern, J Nilsen, HT Noordzij, I Sandlie, JT Andersen
Frontiers in immunology 5, 118912, 2015
3212015
Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential
NM Stapleton, JT Andersen, AM Stemerding, SP Bjarnarson, RC Verheul, ...
Nature communications 2 (1), 599, 2011
2982011
Dependence of antibody-mediated presentation of antigen on FcRn
SW Qiao, K Kobayashi, FE Johansen, LM Sollid, JT Andersen, E Milford, ...
Proceedings of the National Academy of Sciences 105 (27), 9337-9342, 2008
2942008
Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8− CD11b+ dendritic cells
K Baker, SW Qiao, TT Kuo, VG Aveson, B Platzer, JT Andersen, I Sandlie, ...
Proceedings of the National Academy of Sciences 108 (24), 9927-9932, 2011
2272011
Cross-species Binding Analyses of Mouse and Human Neonatal Fc Receptor Show Dramatic Differences in Immunoglobulin G and Albumin Binding 2
JT Andersen, MB Daba, G Berntzen, TE Michaelsen, I Sandlie
Journal of biological chemistry 285 (7), 4826-4836, 2010
2142010
Extending half-life by indirect targeting of the neonatal Fc receptor (FcRn) using a minimal albumin binding domain
JT Andersen, R Pehrson, V Tolmachev, MB Daba, L Abrahmsén, ...
Journal of biological chemistry 286 (7), 5234-5241, 2011
2102011
Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor
JT Andersen, B Dalhus, J Cameron, MB Daba, A Plumridge, L Evans, ...
Nature communications 3 (1), 610, 2012
2052012
The role of albumin receptors in regulation of albumin homeostasis: Implications for drug delivery
M Bern, KMK Sand, J Nilsen, I Sandlie, JT Andersen
Journal of Controlled Release 211, 144-162, 2015
1942015
Extending serum half-life of albumin by engineering neonatal Fc receptor (FcRn) binding
JT Andersen, B Dalhus, D Viuff, BT Ravn, KS Gunnarsen, A Plumridge, ...
Journal of Biological Chemistry 289 (19), 13492-13502, 2014
1802014
Delivery of an erythropoietin-Fc fusion protein by inhalation in humans through an immunoglobulin transport pathway
JA Dumont, AJ Bitonti, D Clark, S Evans, M Pickford, SP Newman
Journal of aerosol medicine 18 (3), 294-303, 2005
1542005
Binding to nanopatterned antigens is dominated by the spatial tolerance of antibodies
A Shaw, IT Hoffecker, I Smyrlaki, J Rosa, A Grevys, D Bratlie, I Sandlie, ...
Nature nanotechnology 14 (2), 184-190, 2019
1482019
The conserved histidine 166 residue of the human neonatal Fc receptor heavy chain is critical for the pH‐dependent binding to albumin
JT Andersen, J Dee Qian, I Sandlie
European journal of immunology 36 (11), 3044-3051, 2006
1432006
Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model
H Almåsbak, E Walseng, A Kristian, MR Myhre, EM Suso, LA Munthe, ...
Gene therapy 22 (5), 391-403, 2015
1382015
The versatile MHC class I-related FcRn protects IgG and albumin from degradation: implications for development of new diagnostics and therapeutics
JT Andersen, I Sandlie
Drug metabolism and pharmacokinetics 24 (4), 318-332, 2009
1312009
Evaluation of the effects of remdesivir and hydroxychloroquine on viral clearance in COVID-19: a randomized trial
A Barratt-Due, IC Olsen, K Nezvalova-Henriksen, T Kåsine, ...
Annals of internal medicine 174 (9), 1261-1269, 2021
1202021
Receptor‐mediated endocytosis of immune complexes in rat liver sinusoidal endothelial cells is mediated by FcγRIIb2
SA Mousavi, M Sporstøl, C Fladeby, R Kjeken, N Barois, T Berg
Hepatology 46 (3), 871-884, 2007
1202007
Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn
RF Hallstensen, G Bergseth, S Foss, S Jæger, T Gedde-Dahl, J Holt, ...
Immunobiology 220 (4), 452-459, 2015
1162015
TRIM21—from intracellular immunity to therapy
S Foss, M Bottermann, A Jonsson, I Sandlie, LC James, JT Andersen
Frontiers in Immunology 10, 2049, 2019
1072019
The system can't perform the operation now. Try again later.
Articles 1–20